AG-73305

N/A

Report date: 2023/08/22 17:03:43

Base Information

Drug NameAG-73305
Drug Alias NameAnti-VEGF/disintegrin fusion protein (Allgenesis Biotherapeutics)AG-73305AM-305AM305
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionAnti-Vascular endothelial growth factorIntegrin antagonists
TargetsVascular endothelial growth factorIntegrin
Therapy Area/IndicationsDiabetic macular oedemaRetinal Vein OcclusionMacular Degeneration
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesSouth KoreaMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPreclinical
Originator CompaniesAllgenesis Biotherapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesAffamed Therapeutics LtdAllgenesis Biotherapeutics Inc
Inactive CompaniesN/A
Active IndicationsDiabetic macular oedemaRetinal Vein OcclusionMacular Degeneration
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A